MedPath

Xenogenous Collagen Matrix Graft With or Without Enamel Matrix Proteins Derivative for Root Coverage

Phase 4
Completed
Conditions
Gingival Recession
Registration Number
NCT02456337
Lead Sponsor
University of Campinas, Brazil
Brief Summary

The purpose of this study is to evaluate the reduction of gingival recession of single Miller Class I and II defects treated by coronally advanced flap with subepithelial porcine collagen matrix graft and / or enamel matrix proteins.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria
  • Age ≥ 18 years.
  • Presence of at least one Class I or II Miller gingival recession ≥ 2.5 mm in maxillary canines or premolars with identifiable cementum-enamel junction (CEJ) and without deep non-carious cervical lesions (< 0.5 mm): A +(Pini-Prato et al. 2010).
  • Aesthetic complaint and/or presence of dentin hypersensitivity to air stimulus.
  • Full-mouth visible plaque index ≤ 20% (Ainamo & Bay 1975).
  • Full-mouth sulcus bleeding index ≤ 20% (Mühlemann & Son 1971).
Exclusion Criteria
  • Smoking.
  • Pregnancy.
  • Presence of systemic disorders (diabetes, hypertension, heart disease or any other condition that could contraindicate periodontal surgery).
  • Use of medications (immunosuppressants, phenytoin or anything else that might affect mucosal healing and repair).
  • Previous periodontal surgery in the area.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Recession Reduction6 months

Measured as a difference between gingival margin between gingival recession depth at baseline and gingival recession at 6 months follow-up.

Secondary Outcome Measures
NameTimeMethod
Complete root coverage6 months

Assessed as percentage of sites with complete root coverage

Trial Locations

Locations (1)

Piracicaba Dental School, State University of Campinas

🇧🇷

Piracicaba, São Paulo, Brazil

Piracicaba Dental School, State University of Campinas
🇧🇷Piracicaba, São Paulo, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.